The S&P BSE HEALTHCARE Index stood at around 42,710.1, down 1.9%. Over the last 30 days, the index had gained 1.3%, and over the past year, it rose 8.8%.
The benchmark S&P BSE SENSEX was at 76,664.79, down 2.86%. (Note: Real-time updates later in the day showed further declines in major indices due to external factors like rising crude oil prices and geopolitical tensions, but the provided data reflects early morning levels.)
Key pharma stock prices and changes (early March 9, 2026):
- Sun Pharma: BSE 1,780.35 (-1.03%), NSE 1,780.00 (-1.08%)
- Divis Laboratories: BSE 6,208.00 (-1.89%), NSE 6,220.50 (-1.71%)
- Cipla: BSE 1,303.90 (-1.35%), NSE 1,305.70 (-1.17%)
- Dr. Reddy’s Lab: BSE 1,280.90 (-1.76%), NSE 1,289.70 (-1.08%)
- Torrent Pharma: BSE 4,280.80 (-0.63%), NSE 4,279.00 (-0.90%)
- Lupin: BSE 2,294.60 (-2.13%), NSE 2,299.60 (-1.89%)
- Aurobindo Pharma: BSE 1,208.20 (-1.90%), NSE 1,210.90 (-1.70%)
- Alkem Laboratories: BSE 5,462.70 (-1.40%), NSE 5,476.50 (-0.97%)
- Mankind Pharma: BSE 2,142.25 (-2.02%), NSE 2,147.10 (-1.82%)
- Zydus Lifesciences: BSE 893.90 (-2.09%), NSE 893.85 (-2.10%)
Other notable stocks included:
- Abbott India: BSE 27,014.95 (-1.21%), NSE 26,990.00 (-1.23%)
- Ajanta Pharma: BSE 2,929.05 (-2.07%), NSE 2,928.30 (-2.13%)
- Glenmark Pharma: BSE 2,066.75 (-2.61%), NSE 2,072.50 (-2.44%)
- Biocon: BSE 382.00 (-2.16%), NSE 383.55 (-1.83%)
- Laurus Labs: BSE 994.10 (-3.06%), NSE 995.00 (-3.04%)
Within the sector, some smaller stocks showed varied performance, with top gainers including Fervent Synergies (up 11.1%) and Medi Caps (up 8.3%), while losers included Parmax Pharma (down 14.3%) and Dr Habeebullah Life Sciences (down 10.0%).
This data is based on early trading snapshots from March 9, 2026, and stock prices can fluctuate throughout the session. For the latest quotes, refer to official BSE/NSE sources or financial platforms.